Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids

ClinicalTrials.gov ID: NCT00053560

Public ClinicalTrials.gov record NCT00053560. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Multi-Center, Placebo- Controlled Study to Assess Prevention of Bone Loss by Treatment With GL701 (Prestara) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical trial is to study the effects of GL701 on bone mineral density in women with active systemic lupus erythematosus (SLE) who are also receiving treatment with glucocorticoids (e.g., prednisone).

Study identification

NCT ID
NCT00053560
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Genelabs Technologies
Industry
Enrollment
155 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2002 (Type not available)
Primary completion
Not listed
Completion
Aug 2004 (Type not available)
Last update posted
Jan 7, 2008

2002 – 2004

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
University of Arizona Tucson Arizona 85724 —
Wallace Rheumatic Study Center Los Angeles California 90048 —
Peng T Fan, MD & Wonil Lee, MD Partnership North Hollywood California 91607 —
Lifestyles Health Science Center Rancho Mirage California 92270 —
University of California San Diego San Diego California 92093-0943 —
East Bay Rheumatology Group San Leandro California 94578 —
Center for Rheumatology, Immunology and Arthritis Fort Lauderdale Florida 33334 —
Rheumatology Associates of Central Florida Orlando Florida 32806-6264 —
Tampa Medical Group, P.A. Tampa Florida 33614 —
Northwestern University Chicago Illinois 60611 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
Johns Hopkins University Baltimore Maryland 21205 —
St. John's Medical Research Group Springfield Missouri 65804 —
Washington University School of Medicine St Louis Missouri 63110 —
SUNY Downstate Medical Center Brooklyn New York 11203 —
North Shore University Hospital, Division of Rheumatology Manhasset New York 11030 —
Albert Einstein Medical School The Bronx New York 10461 —
Oklahoma Center for Arthritis Therapy Tulsa Oklahoma 74114 —
Oregon Health & Science University Portland Oregon 97201 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
University of Pittsburgh Pittsburgh Pennsylvania 15261 —
Vanderbilt University Nashville Tennessee 37232 —
University of Texas, Medical Branch Galveston Texas 77555 —
Sentara Medical Group DBA Virginia Beach Virginia 23462 —
Seattle Rheumatology Associates Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00053560, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 7, 2008 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00053560 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →